BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20421722)

  • 1. Epigenetic regulation of Wnt signaling pathway in urological cancer.
    Costa VL; Henrique R; Ribeiro FR; Carvalho JR; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
    Epigenetics; 2010 May; 5(4):343-51. PubMed ID: 20421722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
    Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
    Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
    Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
    Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic deregulations of Wnt/β-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.
    Singh V; Singh AP; Sharma I; Singh LC; Sharma J; Borthakar BB; Rai AK; Kataki AC; Kapur S; Saxena S
    J Cancer Res Ther; 2019; 15(1):192-203. PubMed ID: 30880778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
    Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
    Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
    BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
    Varol N; Konac E; Bilen CY
    Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
    Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
    Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.